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1. Introduction 
The paraoxonase (PON, aryldialkyl phosphatase, E.C. 3.1.8.1), is an Ca-dependant enzyme that 
is synthesised in liver. It is related to HDL and has 43-45 kDa molecular weight with 
glycoprotein structure. PON is an hydrolase that has both arylesterase (E.C. 3.1.1.2) and 
paraoxonase (E.C. 3.1.8.1) activity (Başkol and Köse, 2004). The name of paraoxonase is 
comes from its useage of organic phosphorous paraoxanes as substrate. Enzyme catalyses 
the hydrolysis of organic phosphorous insecticides such as diisopropyl fluorophosphate 
(DEP) except parathion and catalyses the hydrolysis of nerve gases such as sarin, taurin 
which are in the same chemical group. Howewer, natural substrate of PON is not definite 
(Gülcü and Gürsu, 2003). 
 
 
The paraoxonase was coincided initially in high density lipoproteins after electrophoresis of 
human serum in 1961 (Mackness and Mackness, 2004). Then, it was shown that especially 
purified cattle serum paraoxonase is related to lipids and has the same molecular mass with 
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the lipid complex. With ultracentrifugation of serum, Mackness et al. (1985) reported that 
paraoxonase is carried in HDL structure in human blood. It is determined that the enzyme 
activity is related to HDL particules that contain Apo A1 in sheep (Bayrak et al., 2005). 
Recently, it is shown that human serum paraoxonase is related to the types of HDL which 
contains Apo AI and Apo J (Azarsız and Sözmen, 2000 ; Bayrak et al., 2005).  
2. Izoenzymes of paraoxonase  
There are three members of the PON gene family: PON1, PON2, and PON3. They all 
possess antioxidant properties, share 65% similarity at the amino acid level, and the genes 
are located in tandem on chromosome 7 in humans and on chromosome 6 in mice. 
Althought the amino acid chains of three PON proteins are similar 65 % in proportion, 
their expressions in tissues and dispersions are different from each other. PON1 and 
PON3 are mostly expressed in the liver and are carried in plasma bound to HDL. PON2 
was found only in cells (human endothelial cells and human aortic smooth muscle cells) 
and may not be associated with lipoproteins (Hong-Liang et al., 2003; Aviram and 
Rosenblat, 2004).  
Human serum paraoxonase (PON1) is the most studied family member. The 45 kDa, 354-
amino acid glycoprotein encoded by the PON1 gene maps to human chromosome 7q21-22. 
PON1 is synthesized in liver and is found in various tissues and plasma; especially liver, 
kidneys and intestines. The enzyme takes place in structure of HDL in plasma (Ali et al., 
2003). Calcium is required for both activity and stability of enzyme and plays a role in 
catalytical mechanism. The PON1 arylesterase and PON activities are calcium-dependent 
and can be totally and irreversibly inhibited by EDTA, while the protection of LDL against 
oxidation may not require calcium (Bayrak et al., 2005). Serum PON1 activity is inversely 
associated with oxidative stress not only in serum, but also in arterial macrophages, the 
hallmark of early atherogenesis, and this phenomenon is associated with enhanced 
atherosclerotic lesion formation. PON1 has gained currency about its antioxidant properties 
(Aviram and Rosenblot, 2004). 
The izoenzyme PON2 is especially found in endothelial layer of liver, kidneys, heart, brain 
and testicular tissues (Bayrak et al., 2005). Immunohistochemical methods show that PON2 
is also found in smooth muscle cells of aorta as well (Hong-Liang et al., 2003). Eventhough 
PON2 is defined following PON1 and less studied, it attracted more attention due to its 
antioxidant activity in endothelium and vascular endothelial cells (Bayrak et al., 2005). 
As PON1, PON3 is basically in liver and found in plasma with HDL (Bayrak et al., 2005). 
PON2 and PON3 can not hydrolize paraoxonase because there is not any lysine residue in 
105. position. However, the two izoenzymes (PON2 and PON3) were both suggested to 
possess antioxidant properties, as rabbit serum PON3 protects LDL from oxidation, and it 
rapidly hydrolyzes lactones. (Aviram and Rosenblat, 2004; Ekmekçi et al., 2004).  
3. Structure of paraoxonase 
PON1 enzyme includes 354 amino acids and three carbonhydrate chains that form 15.8 % of 
total mass. The gene which codes PON1 enzyme, is in q 21-22 zone of seventh chromosome. 
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Its isoelectric point pH is 5.1. Amino acid content does not show any specific property 
(Gülcü and Gürsu, 2003).  
PON1 has three cysteine amino acids in its structure. While there are disulphide bonds 
between the two of cysteine amino acids of the enzyme (Cys 42-352), the other cysteine 
amino acid at 284. position is free (Figure 1). This free cysteine is present next to the active 
site of the enzyme and has functions on substrate recognization and binding to enzyme 
(Azarsız and Sözmen, 2000; Bayrak et al., 2005). Although free cysteine has significant effect 
on LDL protection from oxidation, it has no effect on hydrolysis of organophosphates 
(Ekmekçi et al., 2004). On the other hand, the disulphide bond which is found in the 
structure of PON1 is responsible from the cyclic form of the polypeptide chain 
(Memişoğulları and Orhan, 2010). 
 
Fig. 1. The structure of paraoxonase enzyme  
PON1, which is located in HDL structure, is synthesised in liver. N-terminal hydrophobic 
signal peptide of PON1, is required for interaction with HDL. By this signal peptid the 
enzyme is attached onto phospolipid and lipoproteins. Also the binding subunits of HDL 
with PON1, contain Apolipoprotein (Apo) A1 and Apo J (clusterin) proteins. And it is 
considered that Apo 1 and Apo J may affect binding (Başkol and Köse, 2004). 
In three dimension structure of the enzyme, there are two calcium ions having 7.4 Å 
intervals in the centre of β-layers. One of these is the structural calcium and its removal from 
the structure causes irreversible denaturation. The other calcium takes role in catalytic 
action of the enzyme. This calcium ion interacts with one water molecule and the oxygene of 
phosphate ion (Khersonsky and Tawfik, 2005). 
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4. Factors affecting paraoxonase activity 
Serum PON1 activity is affected by diet, pregnancy, smoking, hormones, acute phase 
proteins and age. PON1 activity in newborns and premature infants is half of adult PON1 
activity, only after a year it reaches its adult level. PON1 activity decreases with age (Biasioli 
et al., 2003; Seres et al., 2004), but enzyme activity does not vary by sexes (Azarsız and 
Sözmen, 2000; Ekmekçi et al., 2004).  
It is shown that diet which is rich in saturated fats, reduces satiety serum PON/arylesterase 
activity, and diet that is rich in unsaturated fats, incerases satiety serum PON/arylesterase 
activity (Laplaud et al., 1998). Beside this, it was shown that in adult men PON1 activity 
increases by moderate alcohol consumption (Azarsız and Sözmen, 2000). 
It was also shown that red wine and polyphenol intake increase the PON activity in rats 
with Apo E deficiency, while smoking inhibits PON1 activity (Azarsız and Sözmen, 2000). 
The disorders affecting metabolism of Apo AI, have an effect on PON1 activity as well 
(Azarsız and Sözmen, 2000). 
5. The functions of paraoxonase  
The paraooxonase enzyme has very important functions in organism: 
5.1 Protein against organophosphate (Hydrolic activity) 
Paraoxonase is a calcium-dependent esterase that was initially identified by its hydrolysis of 
aromatic carboxylic esters and organophosphorus insecticides and nerve gases. Its name 
reflects its ability to hydrolyze paraoxon, a metabolite of the insecticide parathion (Cabana 
et al., 2003). The enzyme hydrolyses of O-P ester bond in paraoxon (Ekmekçi et al., 2004). 
Oxons, which do not go through detoxification in mammal liver, are hydrolysed by serum 
PON1 enzyme before the organophosphates display their activity (Azarsız and Sözmen, 
2000).  
Enzyme also catalyses the hydrolysis of various carbamates and aromatic carboxylic acid 
esters such as phenylacetate, 4-nitrophenylacetate, 2-naphtyl acetate (Gülcü and Gürsu, 




The insects are target organisms for organophosphates. Because PON1 cannot be 
synthesised in insects, birds, fish and reptiles. Therefore, there is a tendency for 
organophosphate poisoning in birds, fishes and reptiles, compared to mammals (Azarsız 
and Sözmen, 2000). 
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Earlier studies on the toxicology of organophosphate pesticides revealed that, having low 
serum PON1 activity increases the senstivity to the acute effects of organophosphate 
compounds (Costa and Furlong, 2003). Following determination of the sequence of the 
gene encoding PON1, identification of polymorphisms that lead to differences among 
people in the activity and level of expression of the enzyme, led to the idea that people 
with low PON1 activity may be more sensitive to organophosphate poisoning (Li and 
Costa, 2000) 
In studies carried out in recent years, it was shown that injection of purified PON1 to 
animals that are exposed to organophosphate pesticides, and thus increasing serum PON1 
levels artificially, it was possible to reduce the toxic effects of certain organophosphates like 
chlorpyrifos and diazinon; but this application was observed to be ineffective against 
parathion exposure (Main, 1956). 
In studies carried out in recent years, it was observed that injection of purified PON1 
protects against chlorpyrifos and diazinon but was not effective against parathion exposure. 
In order to be used as a prophylactic agent against organophosphate exposure, PON1’s 
catalytic efficiency has to be increased and the enzyme has to be obtained in adequate 
amounts. In recent years, using protein engineering methods, changes were made to some 
amino acids of PON1, these PON1 variants were expressed in bacterial systems at sufficient 
levels and increase in enzyme activity against some organophosphates were obtained (Harel 
and Brumshtein, 2007). 
These studies relevantly shows that PON1 has a role on the metabolism of some 
organophosphates and an artificial addition of PON1 to serum levels of these animals 
provides a proection against organophosphates toxicities. 
5.2 Prevention of LDL oxidation (Anti-atherogenic activity) 
The second important function of PON1 is its anti-atherogenic activity. Serum PON1 exists 
with HDL in plasma and works to prevent the oxidation of plasma lipoproteins (Aviram, 
1999). PON1 is effective on lipid peroxides and also on hydrogen peroxide therefore, it is 
considered to have activity like peroxidase (Memişoğulları and Orhan, 2010).  
Serum PON1 activity is especially important for the protection of LDL phospholipids 
against oxidation. In the protective effect against atherosclerosis, LDL has different anti-
atherogenic features such as protection from free radical induced oxidation of LDL 
cholesterol in arthery wall and protection against harmful effects of oxi-LDL (Aviram, 1999). 
In addition to LDL, enzyme protects HDL too which is a carrier of lipid peroxide (Azarsız 
and Sözmen, 2000).  
5.3 Protection against bacterial endotoxins(Lipopolysaccharide inactivation) 
In recent studies, it was defined that HDL-associated PON1 protects the body against 
bacterial endotoxin via hydrolysis of bacterial lipopolysaccharides (Bayrak et al., 2005). 
PON1 hydrolyses bacterial lipopolysaccharides with its phosphatase effect. Also the enzyme 
prevents the inflammatory response by avoiding the interaction between specific 
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macrophage binding protein and bacterial lipopolysaccharide (Aviram, 1999, Azarsız and 
Sözmen, 2000). 
6. Role of paraoxonase in oxidative stress 
Reactive oxygen species are oxygen-containing molecules that produced during normal 
metabolism. When the production of damaging reactive oxygene species (ROS) exceeds the 
capacity of the body’s antioxidant defenses to detoxify them, a condition known as oxidative 
stress occurs. Reactive oxygene species can cause tissue damage, particularly in the 
endothelial tissue. Lipids and lipoproteins also affected by ROS (Altındağ et al., 2007). 
Therefore oxidative stress is associated with lipid peroxidation in lipoproteins and in arterial 
cells, including macrophages. Under oxidative stress, not only lipoproteins but lipids in cell 
membrane sustain to lipid peroxidation. Dense and small LDL particles are more sensitive 
to oxidation compared with big particles (Chait et al., 2005).These “oxidized macrophages” 
possess increased capability to convert native LDL into oxidized LDL. Oxidative stress has 
been implicated in the pathogenesis of atherosclerosis. The early atherosclerotic lesion is 
characterized by macrophage foam cells, filled with cholesterol, oxysterols and oxidized 
lipids (Fuhrman et al., 2002). 
HDL associated paraoxonase (PON1) is an antioxidant enzyme that protects LDL and 
HDL from lipid peroxidation. And it is considered to be the main antiatherosclerotic 
(preclusive to atherosclerosis) component of HDL (Gülcü and Gürsu, 2003). PON1 
protects lipoproteins and arterial cells against oxidation, probably by hydrolyzing lipid 
peroxides such as specific oxidized cholesteryl esters and phospholipids. And it was 
suggested to contribute to the antioxidant protection conferred by HDL on LDL oxidation 
(Mackness et al., 1991). 
The PON1 free sulfhydryl group cysteine 284 was shown to be required for its protection 
against lipid peroxidation in lipoproteins (Ekmekçi et al., 2004). It was shown to be reduced 
in patients after myocardial infarction, in patients with familial hypercholesterolemia, and in 
patients with diabetes mellitus in comparison to healthy subjects (Mackness et al., 1991). 
HDL-associated PON was able to hydrolyze long-chain oxidized phospholipids isolated 
from oxidized LDL or serve as a target for peroxides (Figure 2). PON1 through 
interactions between the enzyme-free sulfhydryl group and oxidized lipids. H2O2 is a 
major ROS produced by arterial wall cells during atherogenesis, and it is converted under 
oxidative stress into more potent hydroxyl radical leading to LDL oxidation (Aviram et 
al., 1998). 
PON1 was found to use efficiently not only lipoprotein-associated peroxides (including 
cholesteryl linoleate hydroperoxides), but also hydrogen peroxide (H2O2). PON1 inhibits 
the accumulation of peroxynitrite-generated oxidized phospholipids by its ability to 
hydrolyze phosphatidylcholine (PC) core aldehydes and PC isoprostanes to yield 
lysophosphatidylcholine (Rosenberg et. al., 2003). Because of reducing hydroxide and 
cholesteryl linoleat hydoperoxide in LDL, it is considered that PON1 has an activity like 
peroxidase (Aviram et al., 1998). Thus HDL-PON may play an important role in the 
prevention of atherosclerosis (Aviram et al., 1998). 
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7. The paraoxonase activity in various diseases 
In various diseases, such as obesity, menopause and malnutrition, PON1 activity is being 
suppressed (Yurttagül, 2007). Low PON/HDL and PON/Apo AI rates were seen at patients 
under high atherosclerose risk and it is concluded that the antioxidant capacity of HDL has 
been decreased in these cases (Azarsız and Sözmen, 2000). 
In patients with coronary atherosclerose, the blocker effect of PON1 in LDL oxidation 
occurs with repression of inflammatory response in cells which are on the arterial wall 
with destroying active lipids in LDL (Yurttagül, 2007). In the studies which show PON1 
protects HDL from oxidation, it is revealed that PON1 decreases 95 % rate of lipid 
peroxide and aldehyde accumulation. This protective effect of PON1 on HDL oxidation 
may be related to metal ion chelation, or to a peroxidase-like activity (Aviram et al., 
1998;Yurttagül, 2007). 
It has been shown that in Tropical Theileriosis disease which causes huge economic loss in 
stock farming PON1 activity also decreases (Turunç and Aşkar, 2012). On the other hand, 
PON1 activity also decreases in Dirofilariosis (Heart Worm Disease), which is a zoonotic 
nematode disease. The mature Dirofilaria immitis parasites also make oxidative damage in 




Fig. 2. The role of HDL-associated PON1 in LDL oxidation. 
In Diabetes mellitus (DM), oxidative stress and depending on that, lipid peroxidation 
increases. Oxidised lipids are easily phagocyted by macrophages and they take part in 
atheropatogenesis by generating foam cells. It is determined that PON1 enzyme levels are 
low in DM and in patients with familial hypercholesterolemia (Aviram, 1999). 
8. Conclusion 
Oxidative stress, has been the centre of toxicological studies for possible mechanism of 
toxicity in last decades (Cochranc, 1991). PON1 is a multienzyme complex with hydrolase, 
arylesterase, diaoxonase, phosphatase, peroxidase and lactonase functions. PON1 has also 
antioxidant property, because it prevents the increase of ROS quantity by hydrolysing lipid 
peroxidation products. It also shows protective effect in cell membranes by neutralizing the 
atherogenic effects of lipid peroxides (Aviram et al., 2000). 
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Therefore PON1 is an important enzyme in oxidant-antioxidant status of atherosclerosis 
with its antioxidant effect, but more studies are required for this enzyme to prove it’s role in 
the other diseases. With future studies, the effects of paraoxonase enzyme could be well-
understood. 
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